SEC Form 10-K filed by Eightco Holdings Inc.
Unavailable
Unavailable
Save time and jump to the most important pieces.
8-K - Eightco Holdings Inc. (0001892492) (Filer)
10-K - Eightco Holdings Inc. (0001892492) (Filer)
8-K - Eightco Holdings Inc. (0001892492) (Filer)
SC 13G/A - Eightco Holdings Inc. (0001892492) (Subject)
4 - Eightco Holdings Inc. (0001892492) (Issuer)
3 - Eightco Holdings Inc. (0001892492) (Issuer)
4 - Eightco Holdings Inc. (0001892492) (Issuer)
SAFETY HARBOR, Florida, April 06, 2023 (GLOBE NEWSWIRE) -- Eightco Holdings Inc., a publicly-traded company listed on NASDAQ under the ticker symbol OCTO, is pleased to announce that it will be releasing its comprehensive annual financial results and operational update for the year 2022. This eagerly-anticipated release is scheduled to take place on or before Monday, April 17, 2023 and will provide a comprehensive overview of the company's financial performance and operational activities throughout the previous year. About Eightco Holdings Inc. Eightco Holdings Inc. (NASDAQ:OCTO) is committed to growth focused around its existing subsidiaries, Forever 8, an inventory management platform
Easton, PA, April 28, 2025 (GLOBE NEWSWIRE) -- Eightco Holdings Inc. (NASDAQ:OCTO) (the "Company" or "Eightco") today announced the appointment of Nicola Caiano to its Board of Directors. Mr. Caiano brings over three decades of expertise in financial strategy, capital markets, and investment management, further strengthening Eightco's strategic vision and growth trajectory. Mr. Caiano currently serves as Chief Financial Officer at Cytometric Therapeutics, where he leads capital formation strategies to fund clinical trials for groundbreaking cancer therapies. He is also the Founding Partner of Olea Management LLC, where he advises family offices and early-stage companies across diverse ind
2024 revenues of $39.6 million down from $67.6 million, driven by reduction in capital available for cell phone sales after repayment of the previously outstanding convertible note2024 Gross Profit of $6.0 million, down from $6.2mn Easton, PA, April 15, 2025 (GLOBE NEWSWIRE) -- Eightco Holdings Inc. (NASDAQ:OCTO) (the "Company" or "Eightco"), today announced financial results for the fiscal year ended December 31, 2024. Paul Vassilakos, CEO of Eightco and President of Forever 8 Fund, LLC ("Forever 8"), the Company's largest subsidiary, said "We continue to improve all aspects of our cost structure and focus on our highest growth priorities to deliver long-term value to shareholders. In t
Strategic Divestiture Continues Focus on Core Forever 8 Business' Long-Term Growth Easton, PA, April 11, 2025 (GLOBE NEWSWIRE) -- Eightco Holdings Inc. (NASDAQ:OCTO) (the "Company" or "Eightco") today announced that it has completed the sale of its subsidiary, Ferguson Containers, Inc., to Reichard Corrugated Products, LLC, an entity controlled by the existing management of Ferguson Containers. "We are pleased to announce the sale of Ferguson Containers. This planned divestiture is a milestone that will allow both companies to better position themselves for long-term success and aligns with our focus on our core business," said Paul Vassilakos, CEO of Eightco and President of Forever 8 F
Easton, PA, April 28, 2025 (GLOBE NEWSWIRE) -- Eightco Holdings Inc. (NASDAQ:OCTO) (the "Company" or "Eightco") today announced the appointment of Nicola Caiano to its Board of Directors. Mr. Caiano brings over three decades of expertise in financial strategy, capital markets, and investment management, further strengthening Eightco's strategic vision and growth trajectory. Mr. Caiano currently serves as Chief Financial Officer at Cytometric Therapeutics, where he leads capital formation strategies to fund clinical trials for groundbreaking cancer therapies. He is also the Founding Partner of Olea Management LLC, where he advises family offices and early-stage companies across diverse ind